Another mechanism regarding the actions of PGRN covers the formation of protein tyrosine kinase 2 (PTK2) and paxillin (PXN) complex through ERK1/2 activation that promotes cell invasion and migration, as observed in bladder cancer and mesothelioma [56,81]. This evidence concerns the gene PTK2 and urinary bladder carcinoma.